InvestorsHub Logo
Followers 839
Posts 120737
Boards Moderated 13
Alias Born 09/05/2002

Re: DC15 post# 2585

Friday, 07/07/2023 5:15:10 PM

Friday, July 07, 2023 5:15:10 PM

Post# of 3466
Could be related to the HBV program. A few companies are testing combination regimens in HBV that include an immunotherapy component.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News